![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/4-Figure2-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos 4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos](https://zaguan.unizar.es/record/78052/files/texto_completo.jpg?subformat=icon)
4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos
Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagno
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/1c9dc49e-b7f0-494a-8696-a6fff2ae90ed/gr2_lrg.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
![A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-019-0553-6/MediaObjects/12894_2019_553_Fig3_HTML.png)
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/4-Figure1-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429514002490-gr1.jpg)
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpcan.2016.57/MediaObjects/41391_2017_Article_BFpcan201657_Fig1_HTML.jpg)
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1532046415000805-fx1.jpg)
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/2-Table1-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/adf2d3f5-f120-4033-88a6-3fc175a7a0aa/gr1.jpg)
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig2_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis](https://www.mdpi.com/cancers/cancers-12-03790/article_deploy/html/images/cancers-12-03790-g001.png)